SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-222600
Filing Date
2011-08-15
Accepted
2011-08-15 12:11:09
Documents
9
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 666371
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex311.htm EX-31.1 6981
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 dex312.htm EX-31.2 6935
4 CERTIFICATIONS OF THE PEO AND PFO PURSUANT TO SECTION 906 dex321.htm EX-32.1 4453
  Complete submission text file 0001193125-11-222600.txt   2217613

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ngsx-20110630.xml EX-101.INS 281586
6 XBRL TAXONOMY EXTENSION SCHEMA ngsx-20110630.xsd EX-101.SCH 11707
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ngsx-20110630_cal.xml EX-101.CAL 38491
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ngsx-20110630_lab.xml EX-101.LAB 110245
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ngsx-20110630_pre.xml EX-101.PRE 67955
Mailing Address 2215 BRIDGEPOINTE PARKWAY SUITE 200 SAN MATEO CA 94404
Business Address 2215 BRIDGEPOINTE PARKWAY SUITE 200 SAN MATEO CA 94404 650-358-3300
NeurogesX Inc (Filer) CIK: 0001385830 (see all company filings)

IRS No.: 943307935 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33438 | Film No.: 111034438
SIC: 2834 Pharmaceutical Preparations